[Long-term effect of a new beta-agonist prenalterol in patients with severe congestive heart failure (author's transl)].
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004452:Echocardiography; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D011217:Practolol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011294:Prenalterol; D011897:Random Allocation
D000318:Adrenergic beta-Agonists; D011294:Prenalterol; D011217:Practolol
Langzeitwirkung des neuen Beta-Agonisten Prenalterol bei Patienten mit schwerer Herzinsuffizienz III--IV.